母嬰保健知識描述：：Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-22-226465  Act: 34  Size: 168 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-22-282556  Act: 33  Size: 293 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-053303  Size: 7 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-053301  Size: 9 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-028805  Size: 18 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-061441  Size: 7 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-22-028435  Act: 34  Size: 581 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-059418  Size: 10 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-039387  Size: 18 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-22-028434  Act: 34  Size: 12 MB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-056210  Size: 9 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-22-282749  Act: 33  Size: 490 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-22-037378  Act: 34  Size: 589 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-059415  Size: 9 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-048759  Size: 6 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-061442  Size: 9 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-053304  Size: 9 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-22-313730  Act: 34  Size: 167 KB 網頁鏈接 Chinook Therapeutics(KDNY)： Chinook Therapeutics(KDNY) 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-22-037390  Act: 34  Size: 12 MB 網頁鏈接